The Use of 23-Valent Pneumococcal Polysaccharide Vaccine in Patients with Rheumatoid Arthritis

The Use of 23-Valent Pneumococcal Polysaccharide Vaccine in Patients with Rheumatoid Arthritis

Objective: to study the clinical efficacy, immunogenicity, and safety of a 23-valent pneumococcal vaccine in patients with rheumatoid arthritis (RA).Subjects and methods. The investigation enrolled 102 patients (78 women and 24 men, aged 23 – 70 years), including 72 patients with RA and 30 people wi...

Full description

Bibliographic Details
Main Authors:	M. S. Naumtseva, B. S. Belov, G. M. Tarasova, D. E. Karateev, E. L. Luchikhina, Yu. V. Muravyev, E. N. Aleksandrova, A. A. Novikov
Format:	Article
Language:	Russian
Published:	Numikom LLC 2015-08-01
Series:	Эпидемиология и вакцинопрофилактика
Subjects:	ревматоидный артрит аутоиммунные заболевания коморбидные инфекции коморбидность пневмония бронхиты пневмококковая вакцина вакцинация иммуногенность эффективность переносимость
Online Access:	https://www.epidemvac.ru/jour/article/view/384

Similar Items

Immunogenicity and efficiency of a 23-valent pneumococcal vaccine in patients with rheumatoid arthritis: results of a 5-year follow up study
by: D. V. Bukhanova, et al.
Published: (2018-12-01)

Herpes zoster virus infection and rheumatic diseases: Current state of the problem
by: D. V. Bukhanova, et al.
Published: (2016-09-01)

Vaccination in rheumatology: the present and prospects
by: Boris Sergeyevich Belov, et al.
Published: (2012-09-01)

Specific features of comorbidity in rheumatoid arthritis patients in different follow-up years
by: N. M. Nikitina, et al.
Published: (2015-03-01)

Infectious comorbidities in patients with rheumatoid arthritis: Status praesens
by: B. S. Belov, et al.
Published: (2019-09-01)

Comorbid infections in patients with rheumatoid arthritis
by: B.S. Belov
Published: (2014-05-01)

Problems of treatment adherence in patients with rheumatoid arthritis and comorbidity
by: N. M. Nikitina, et al.
Published: (2020-10-01)

The effectiveness of immunization of children against Pneumococcal infection in Penza, Russia
by: O. N. Lesina, et al.
Published: (2019-04-01)

Safety and efficacy of 23-valent polysaccharide pneumococcal vaccine in patients with systemic lupus erythematosus
by: G. M. Tarasova, et al.
Published: (2021-06-01)

THE EXPERIENCE OF PNEUMOCOCCAL CONJUGATE VACCINE USAGE IN ORPHANAGE INSTITUTION OF THE REPUBLIC OF MORDOVIA
by: A. A. Brovkina, et al.
Published: (2012-11-01)

Efficacy and Safety of Immunization With Pneumococcal Polysaccharide Vaccine in Children With Juvenile Idiopathic Arthritis: Preliminary Results of a Prospective Open-Label Study
by: Ekaterina I. Alexeeva, et al.
Published: (2017-06-01)

Experience of Vaccination of a Patient with Systemic Juvenile Idiopathic Arthritis (sJIA) with a 13-Valent Pneumococcal Conjugate Vaccine, prior to the Appointment of Therapy with Tocilizumab, an Anti-IL-6-Receptor Monoclonal Antibody
by: Daria D. Vankova, et al.
Published: (2018-10-01)

PREVALENCE OF PNEUMOCOCCAL PNEUMONIAE AND OTITIDES IN INFANTS (PROVISIONAL DATA)
by: S.M. Kharit, et al.
Published: (2011-11-01)

Modern Approaches to Vaccinal Prevention of a Pneumococcal Infection in Adults Patients with Diabetes Mellitus (Literature Review)
by: J. A. Paramonova, et al.
Published: (2018-04-01)

Efficacy of Pneumococcal Polysaccharide Conjugate Vaccine (13-valent, Adsorbed) in Patients with Systemic Juvenile Idiopathic Arthritis Treated with Genetically Engineered Biologic Drugs (Tocilizumab or Canakinumab): Prospective Cohort Study
by: Ekaterina I. Alexeeva, et al.
Published: (2020-08-01)

How real is the long-lasting effect of tumor necrosis factor α inhibitors? Focus on immunogenicity
by: D.E. Karateev
Published: (2014-05-01)

Immunization With a Pneumococcal Polysaccharide Vaccine in Children With Juvenile Idiopathic Arthritis Without Systemic Manifestations: a Prospective Study
by: Ekaterina I. Alexeeva, et al.
Published: (2018-01-01)

Comparison of the efficacy and safety of the original rituximab and its biosimilar in routine clinical practice
by: D. A. Kusevich, et al.
Published: (2022-06-01)

Assessing the status of patients with rheumatoid arthritis: modern tendencies
by: A. M. Lila, et al.
Published: (2020-05-01)

13-valent Pneumococcal Conjugate Vaccine and Haemophilus Influenzae-Tetanus Toxoid Conjugate Vaccine in Patient with Systemic Juvenile Idiopathic Arthritis Receiving Tocilizumab: Clinical Case
by: Ekaterina I. Alekseeva, et al.
Published: (2019-09-01)

Vaccination in persons with systemic lupus erythematosus: the current state of the problem
by: B. S. Belov, et al.
Published: (2022-05-01)

Vaccination as a solution of the issue of resistance S. pneumoniae
by: H. P. Ruban, et al.
Published: (2021-05-01)

Clinical and Immunological Aspects of Pneumococcal Vaccination in Patients with Multiple Myeloma
by: I. O. Stoma
Published: (2021-01-01)

TARGETED THERAPY AND INFECTIONS IN RHEUMATIC DISEASES
by: B. S. Belov, et al.
Published: (2016-12-01)

Prevention of Pneumococcal Infection in Children with Chronic Diseases of the Nasopharynx Reduces the Incidence of Other Respiratory Tract Infections: Results of a Comparative Prospective Study
by: V. P. Vavilova, et al.
Published: (2015-11-01)

Assessing the multimorbid profile (CIRS) in rheumatoid arthritis. First results
by: A. V. Gordeev, et al.
Published: (2019-09-01)

Cost-effectiveness of vaccination against pneumococcal infection of adults at risk within the federal and regional programs
by: A. V. Rudakova, et al.
Published: (2019-12-01)

EU Registries Forum Meeting is a new step in the development of international cooperation in rheumatic diseases registries
by: D. E. Karateev
Published: (2015-06-01)

Golimumab in the treatment of inflammatory diseases: A role of immunogenicity
by: D. E. Karateev
Published: (2016-01-01)

Vaccination in Patients with Chronic Lymphocytic Leukemia: Current Problems
by: M. I. Kislova, et al.
Published: (2021-07-01)

13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE
by: V. K. Tatochenko, et al.
Published: (2012-03-01)

Endothelial dysfunction in patients with rheumatoid arthritis and comorbidity
by: A. K. Knyazeva, et al.
Published: (2018-01-01)

INVESTIGATION OF A ROLE OF THE IMMUNOGENICITY OF INFLIXIMAB IN THE THERAPY OF ANKYLOSING SPONDYLITIS
by: O. A. Rumyantseva, et al.
Published: (2016-09-01)

New Arguments in favor of the Release Active Antiviral Drug to Prepare Children for Vaccination
by: V. P. Vavilova, et al.
Published: (2015-12-01)

Effectiveness of Vaccination against Pneumococcal Infection in Uzbekistan: a Preliminary Assessmant and Prognosis
by: T. A. Daminov, et al.
Published: (2018-12-01)

Comorbid infections in spondyloarthritis: a modern view of the problem
by: N. V. Muravyeva, et al.
Published: (2020-11-01)

Immunogenicity and Safety of a Quadrivalent Meningococcal Tetanus Toxoid-Conjugate Vaccine (MenACYW-TT) Administered Concomitantly with Pneumococcal Conjugate Vaccine in Healthy Toddlers in the Russian Federation: a Phase III Randomized Study
by: L. S. Namazova-Baranova, et al.
Published: (2023-01-01)

Safety of Combination of a Tetravalent Meningococcal Conjugate Vaccine Against Serogroups A, C, Y, W-135 With Other Vaccine Preparations: a Prospective Study of a Series of Cases Among Healthy Children and Children With Various Health Abnormalities
by: Leyla S. Namazova-Baranova, et al.
Published: (2017-06-01)

Factors determining long-term success of biologic therapy in rheumatoid arthritis
by: Dmitry Evgenyevich Karateev
Published: (2015-09-01)

Infections and systemic vasculitis
by: B. S. Belov, et al.
Published: (2022-10-01)